1-11 of 11
Zheng-Yi Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reducing Time Toxicity for Anti-B-Cell Maturation Antigen (BCMA) Bispecific Treatment: Evidence from Pivotal Single-Arm Trial Data on Teclistamab, Elranatamab, and Linvoseltamab for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, Timothy J. Inocencio, Zheng-Yi Zhou, Michael K. Xu, Jack Eales, Michelle Little, Peter Quon, Qiufei Ma
Journal: Blood
Blood (2024) 144 (Supplement 1): 2271.
https://doi.org/10.1182/blood-2024-199182
Published: 2024
Journal Articles

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Joshua Richter, Peggy L Lin, Viviana Garcia-Horton, Patricia Guyot, Zheng-Yi Zhou, Mark Sievert
Journal: Blood
Blood (2023) 142 (Supplement 1): 6734.
https://doi.org/10.1182/blood-2023-188582
Published: 2023
Journal Articles

Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020

Sikander Ailawadhi, Qiufei Ma, Jessica J. Jalbert, Mo Zhou, Zheng-Yi Zhou, Nathaniel Downes, Adina Zhang, Lei Chi, Christian Hampp, Xue Song, Irene Noguera-Troise, Jonathan Weyne, Glenn S. Kroog, Karen Rodriguez Lorenc
Journal: Blood
Blood (2022) 140 (Supplement 1): 5272–5273.
https://doi.org/10.1182/blood-2022-158401
Published: 2022
Journal Articles

Treatment Patterns and Economic Burden Among Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A SEER-Medicare Analysis

Andrew M. Brunner, David Huggar, Ronda Copher, Zheng-Yi Zhou, Miriam L. Zichlin, Annika Anderson, Nathaniel Downes, Ali McBride
Journal: Blood
Blood (2021) 138 (Supplement 1): 4975.
https://doi.org/10.1182/blood-2021-145593
Published: 2021
Journal Articles

Association between Spending in Oncology Care Model-Defined Episodes and Overall Survival in Multiple Myeloma Using 2012-2017 Medicare Data

Ruben Niesvizky, MD, Zoe Clancy, Ronda Copher, PhD, Ryan B. Thomas, MD, Cynthia Z. Qi, MBA, Zheng-Yi Zhou, Miriam L. Zichlin, Sarah H. Koenigsberg, James E. Signorovitch
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-136284
Published: 2020
Journal Articles

Economic Burden of Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Study Using the SEER-Medicare Database

Ashley Tabah, David Huggar, Krystal Huey, Ronda Copher, PhD, Zheng-Yi Zhou, Miriam L. Zichlin, Sarah H. Koenigsberg, Andrew M. Brunner
Journal: Blood
Blood (2020) 136 (Supplement 1): 45.
https://doi.org/10.1182/blood-2020-136768
Published: 2020
Journal Articles

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Arash Mahajerin, MD MS, Zheng-Yi Zhou, PhD, Karina Raimundo, Anisha Patel, Simeng Han, Yusi Ji, Jia Zhong, Keith Betts
Journal: Blood
Blood (2018) 132 (Supplement 1): 3511.
https://doi.org/10.1182/blood-2018-99-112418
Published: 2018
Journal Articles

Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective

Zheng-Yi Zhou, PhD, Kejal Parikh, Xinglei Chai, Ariel Rokito, Chuka Udeze, Jipan Xie, Amit Agarwal
Journal: Blood
Blood (2018) 132 (Supplement 1): 3535.
https://doi.org/10.1182/blood-2018-99-112942
Published: 2018
Journal Articles

Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Acute Myeloid Leukemia and a Subset with IDH1-Mutation: A United States Medical Chart Review Study

James D. Griffin, MD, Mike Storm, MSc, Ken Wilhelm, MD, Audra Boscoe, PhD, Dendy Macaulay, PhD, Zheng-Yi Zhou, PhD, Elizabeth Faust, MBA/MPH, Claudia Cheung, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5864.
https://doi.org/10.1182/blood-2018-99-116495
Published: 2018
Journal Articles

Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis

Sikander Ailawadhi, Kejal Parikh, BSPharm, MS, Zhou Zhou, MS, Wenxi Tang, MS, Zoe Clancy, MS, PharmD, Claudia Cheung, MS, Zheng-Yi Zhou, PhD, Jipan Xie, MD PhD, Safiya Abouzaid, MPH, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3426.
https://doi.org/10.1182/blood.V130.Suppl_1.3426.3426
Published: 2017
Journal Articles

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Tiffany P. Quock, PhD MS, Zheng-Yi Zhou, PhD, Byran Dai, MS, Wenxi Tang, MS, Kathleen F. Villa, MS
Journal: Blood
Blood (2015) 126 (23): 3273.
https://doi.org/10.1182/blood.V126.23.3273.3273
Published: 2015